Literature DB >> 1415256

Different mosaicism frequencies for proximal and distal Duchenne muscular dystrophy (DMD) mutations indicate difference in etiology and recurrence risk.

M R Passos-Bueno1, E Bakker, A L Kneppers, R I Takata, D Rapaport, J T den Dunnen, M Zatz, G J van Ommen.   

Abstract

In about 65% of the cases of Duchenne muscular dystrophy (DMD) a partial gene deletion or duplication in the dystrophin gene can be detected. These mutations are clustered at two hot spots: 30% at the hot spot in the proximal part of the gene and about 70% at a more distal hot spot. Unexpectedly we observed a higher frequency of proximal gene rearrangements among proved "germ line" mosaic cases. Of the 24 mosaic cases we are aware of, 19 (79%) have a proximal mutation, while only 5 (21%) have a distal mutation. This finding indicates that the mutations at the two hot spots in the dystrophin gene differ in origin. Independent support for the different mosaicism frequency was found by comparing the mutation spectra observed in isolated cases of DMD and familial cases of DMD. In a large two-center study of 473 patients from Brazil and the Netherlands, we detected a significant difference in the deletion distribution of isolated (proximal:distal ratio 1:3) and familial cases (ratio 1:1). We conclude from these data that proximal deletions most likely occur early in embryonic development, causing them to have a higher chance of becoming familial, while distal deletions occur later and have a higher chance of causing only isolated cases. Finally, our findings have important consequences for the calculation of recurrence-risk estimates according to the site of the deletion: a "proximal" new mutant has an increased recurrence risk of approximately 30%, and a "distal" new mutant has a decreased recurrence risk of approximately 4%.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1415256      PMCID: PMC1682835     

Source DB:  PubMed          Journal:  Am J Hum Genet        ISSN: 0002-9297            Impact factor:   11.025


  22 in total

1.  Estimate of germinal mosaicism in Duchenne muscular dystrophy.

Authors:  M R Passos-Bueno; M A Lima; M Zatz
Journal:  J Med Genet       Date:  1990-11       Impact factor: 6.318

2.  Topography of the Duchenne muscular dystrophy (DMD) gene: FIGE and cDNA analysis of 194 cases reveals 115 deletions and 13 duplications.

Authors:  J T Den Dunnen; P M Grootscholten; E Bakker; L A Blonden; H B Ginjaar; M C Wapenaar; H M van Paassen; C van Broeckhoven; P L Pearson; G J van Ommen
Journal:  Am J Hum Genet       Date:  1989-12       Impact factor: 11.025

3.  Evidence for kinks in DNA folding in the nucleosome.

Authors:  M E Hogan; T F Rooney; R H Austin
Journal:  Nature       Date:  1987 Aug 6-12       Impact factor: 49.962

4.  Detection of 98% of DMD/BMD gene deletions by polymerase chain reaction.

Authors:  A H Beggs; M Koenig; F M Boyce; L M Kunkel
Journal:  Hum Genet       Date:  1990-11       Impact factor: 4.132

5.  Screening of deletions in the dystrophin gene with the cDNA probes Cf23a, Cf56a, and Cf115.

Authors:  M R Passos-Bueno; D Rapaport; D Love; T Flint; E R Bortolini; M Zatz; K E Davies
Journal:  J Med Genet       Date:  1990-03       Impact factor: 6.318

6.  Complete cloning of the Duchenne muscular dystrophy (DMD) cDNA and preliminary genomic organization of the DMD gene in normal and affected individuals.

Authors:  M Koenig; E P Hoffman; C J Bertelson; A P Monaco; C Feener; L M Kunkel
Journal:  Cell       Date:  1987-07-31       Impact factor: 41.582

7.  Parental origin and germline mosaicism of deletions and duplications of the dystrophin gene: a European study.

Authors:  A J van Essen; S Abbs; M Baiget; E Bakker; C Boileau; C van Broeckhoven; K Bushby; A Clarke; M Claustres; A E Covone
Journal:  Hum Genet       Date:  1992-01       Impact factor: 4.132

8.  The molecular basis for Duchenne versus Becker muscular dystrophy: correlation of severity with type of deletion.

Authors:  M Koenig; A H Beggs; M Moyer; S Scherpf; K Heindrich; T Bettecken; G Meng; C R Müller; M Lindlöf; H Kaariainen; A de la Chapellet; A Kiuru; M L Savontaus; H Gilgenkrantz; D Récan; J Chelly; J C Kaplan; A E Covone; N Archidiacono; G Romeo; S Liechti-Gailati; V Schneider; S Braga; H Moser; B T Darras; P Murphy; U Francke; J D Chen; G Morgan; M Denton; C R Greenberg; K Wrogemann; L A Blonden; M B van Paassen; G J van Ommen; L M Kunkel
Journal:  Am J Hum Genet       Date:  1989-10       Impact factor: 11.025

9.  Germinal mosaicism from grand-paternal origin in a family with Duchenne muscular dystrophy.

Authors:  M Claustres; P Kjellberg; M Desgeorges; H Bellet; J Demaille
Journal:  Hum Genet       Date:  1990-12       Impact factor: 4.132

10.  Somatic mosaicism at the Duchenne locus.

Authors:  R V Lebo; R K Olney; M S Golbus
Journal:  Am J Med Genet       Date:  1990-10
View more
  15 in total

1.  De novo facioscapulohumeral muscular dystrophy: frequent somatic mosaicism, sex-dependent phenotype, and the role of mitotic transchromosomal repeat interaction between chromosomes 4 and 10.

Authors:  S M van der Maarel; G Deidda; R J Lemmers; P G van Overveld; M van der Wielen; J E Hewitt; L Sandkuijl; B Bakker; G J van Ommen; G W Padberg; R R Frants
Journal:  Am J Hum Genet       Date:  2000-01       Impact factor: 11.025

2.  Somatic mosaicism for a PDHA1 mutation in a female with pyruvate dehydrogenase deficiency.

Authors:  Cheryl K Ridout; Ruth M Brown; John H Walter; Garry K Brown
Journal:  Hum Genet       Date:  2008-08-17       Impact factor: 4.132

3.  Somatic mosaicism in hemophilia A: a fairly common event.

Authors:  M Leuer; J Oldenburg; J M Lavergne; M Ludwig; A Fregin; A Eigel; R Ljung; A Goodeve; I Peake; K Olek
Journal:  Am J Hum Genet       Date:  2001-06-14       Impact factor: 11.025

Review 4.  Experience and strategy for the molecular testing of Duchenne muscular dystrophy.

Authors:  Thomas W Prior; Scott J Bridgeman
Journal:  J Mol Diagn       Date:  2005-08       Impact factor: 5.568

5.  Recurrence risk for germinal mosaics revisited.

Authors:  M A van der Meulen; M J van der Meulen; G J te Meerman
Journal:  J Med Genet       Date:  1995-02       Impact factor: 6.318

6.  High proportion of new mutations and possible anticipation in Brazilian facioscapulohumeral muscular dystrophy families.

Authors:  M Zatz; S K Marie; M R Passos-Bueno; M Vainzof; S Campiotto; A Cerqueira; C Wijmenga; G Padberg; R Frants
Journal:  Am J Hum Genet       Date:  1995-01       Impact factor: 11.025

7.  Extensive germinal mosaicism in a family with X linked myotubular myopathy simulates genetic heterogeneity.

Authors:  M C Vincent; C Guiraud-Chaumeil; J Laporte; S Manouvrier-Hanu; J L Mandel
Journal:  J Med Genet       Date:  1998-03       Impact factor: 6.318

8.  Deletion patterns of Duchenne and Becker muscular dystrophies in Greece.

Authors:  L Florentin; A Mavrou; K Kekou; C Metaxotou
Journal:  J Med Genet       Date:  1995-01       Impact factor: 6.318

9.  Integrated study of 100 patients with Xp21 linked muscular dystrophy using clinical, genetic, immunochemical, and histopathological data. Part 1. Trends across the clinical groups.

Authors:  L V Nicholson; M A Johnson; K M Bushby; D Gardner-Medwin; A Curtis; I B Ginjaar; J T den Dunnen; J L Welch; T J Butler; E Bakker
Journal:  J Med Genet       Date:  1993-09       Impact factor: 6.318

10.  On the origin of deletions and point mutations in Duchenne muscular dystrophy: most deletions arise in oogenesis and most point mutations result from events in spermatogenesis.

Authors:  T Grimm; G Meng; S Liechti-Gallati; T Bettecken; C R Müller; B Müller
Journal:  J Med Genet       Date:  1994-03       Impact factor: 6.318

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.